Novartis CEO Joseph Jimenez to Retire in 2018

Wednesday, September 6 2017 | 00 h 00 min | News, Press Release

Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in the position. The Board of Directors has appointed Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as CEO of Novartis, effective February 1, 2018. Dr. Narasimhan is a member of the Executive Committee and joined Novartis in 2005.

Dr. Narasimhan has held numerous leadership positions across Novartis in commercial, drug development and strategy roles. Prior to his current role he served as Head of Development for Novartis Pharmaceuticals.

Dr. Narasimhan said, “I would like to congratulate Joe and express my gratitude to Joe, Joerg, and the Board of Directors. I feel honored and humbled to be asked to lead Novartis. We will continue our legacy of bringing leading innovation to patients around the world.”

Featured Posts

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read More

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read More

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read More

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read More

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more